Pharma sector Current Affairs - 2020

Two Experimental Ebola vaccines found safe, effective in human trial

The clinical trials of two experimental Ebola vaccines cAd3-EBOZ and rVSV-ZEBOV were found to be safe and capable of eliciting immune response against Ebola virus that lasts for at least one year. The findings were based on a study of clinical trials on 1,500 adults that began during West Africa Ebola outbreak. Three groups of Read More…

Government constitute committee to make drugs more affordable

The Union Ministry of Chemicals and Fertilisers has constituted a committee of joint secretaries for ensuring enhanced affordability, availability and accessibility of drugs for the citizens. The committee will suggest ways to make pricing policy in favour of poor patients. Terms of reference of the committee The committee will review the scope of Drugs (Price Read More…

Tags:

NRAI gets highest WHO ratings for vaccine regulations

India’s vaccine regulatory body NRAI (National Regulatory Authority of India) was given the maximum ratings by the World Health Organisation (WHO) for vaccine regulations. The ratings were given by WHO after completing the assessment of the status of the NRAI system against WHO NRA Global Benchmarking Tool and measured the maturity of the system in Read More…

DTAB suggests one-time licensing for drugs

The Drugs Technical Advisory Board (DTAB) recently recommended one-time licensing for manufacture and sales of drugs. If the recommendation is approved it will change present of the renewal of licences for each formulation which rests with state regulators and takes around three years. However, the new rule will have a condition that there be at least Read More…

Delhi High Court reverses ban on fixed dose combination drugs

The Delhi High Court has quashed ban imposed on 344 fixed dose combination (FDC) drugs by the Central Government over fears that they are potential health and safety hazards. The HC held that Centre had acted in a haphazard manner and did not take the advice of the statutory bodies under the Drugs and Cosmetics Read More…